Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
AC-PACLitaxel Treatment
Chemotherapy regimens for breast cancer. | Download Table
Regimen of chemotherapy in triple-negative breast cancers | Download Table
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
Pregnancy-Associated Breast Cancer
Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer -
Early Chemotherapy Dose Reductions May Affect Breast Cancer Outcomes | Cancer Today
What It's Like Going Through AC Chemotherapy — Magda Milczarska
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
AC-T Regimen | Semantic Scholar
Comparative Analysis of the Chemotherapy-related Cognitive Impairments in Patients with Breast Cancer: a Community-based Research | medRxiv
Recommended antiemetic regimens for HEC and AC-containing regimens... | Download Table
AC-T Regimen [Doxorubicin, Cyclophosphamide, Paclitaxel] PHARMACY
Cancer Treatment–Induced Arrhythmias | Circulation: Arrhythmia and Electrophysiology
AC-T Regimen | Semantic Scholar
AC-T Regimen | Semantic Scholar
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials - The Lancet
Breast Cancer Chemo Regime AC + T: What You Should Know
What It's Like Going Through AC Chemotherapy — Magda Milczarska
Frontiers | Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
JCM | Free Full-Text | Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
